Market Place
Sourcing Support
MetaVia to Present at Upcoming Investor and Industry Conferences
26 Aug 2025 //
PR NEWSWIRE
Metavia Reports Q2 2025 Financial Results, Updates on Corporate
08 Aug 2025 //
PR NEWSWIRE
MetaVia extends Phase 1 trial of DA-1726 for obesity to 8 weeks
07 Aug 2025 //
PR NEWSWIRE
MetaVia, Syntekabio collaborate on exploring new DA-1241 uses
04 Aug 2025 //
PR NEWSWIRE
MetaVia Doses First Patient in Phase 1 trial Exploring DA-1726
09 Jul 2025 //
PR NEWSWIRE
MetaVia Reports Q1 2025 Financial Results and Corporate Update
14 May 2025 //
PR NEWSWIRE
MetaVia`s DA-1241 Shows Liver, Glucose Benefits at EASL
07 May 2025 //
PR NEWSWIRE
MetaVia Reports Positive Results From MAD Part 2 of Phase 1 Study
22 Apr 2025 //
PR NEWSWIRE
MetaVia Reports Positive Data From 4-Week Phase 1 Trial of DA-1726
15 Apr 2025 //
PR NEWSWIRE
MetaVia Reports 2024 Financial Results and Corporate Update
20 Mar 2025 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.